Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors

Zhou, JG; Donaubauer, AJ; Frey, B; Becker, I; Rutzner, S; Eckstein, M; Sun, R; Ma, H; Schubert, P; Schweizer, C; Fietkau, R; Deutsch, E; Gaipl, U; Hecht, M

ANNALS OF ONCOLOGY, 2020; 31 (): S1360